TAVI - Durability and long-term outcomes

Session comprising selected PCR London Valves 2023 Abstract submissions

Facilitators: M. Borger, P. Pibarot

Summary

Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore the extended clinical efficacy of TAVs implantation using three different second-generation devices, and more!

Presentations available when logged in:

  • Five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis
  • Long-term outcomes of prosthesis-patient mismatch following valve-in-valve TAVI
  • Long-term clinical efficacy of TAVs implantation with three different second-generation devices
  • Long-term outcomes of patient-prosthesis mismatch after TAVI from the randomised SCOPE-1 trial
  • Ten-year follow-up of patients after TAVI in SIL-TAVI registry
  • Four-year outcomes from the Evolut low risk trial